• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Panitumumab (2)

Pharmacogenomic Information
  

 Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
 
Labeling Sections with
Pharmacogenomic
Information
PanitumumabOncologyKRASKRAS codon 12 and
13 mutation negative
Indications and Usage
Clinical Pharmacology
Clinical Studies

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling